[Primary central nervous system lymphoma following immunotherapy for metastatic melanoma].
CONCLUSION: While immunotherapy cannot be unequivocally incriminated in primary central nervous system lymphoma, this case raises many questions about the imputability of immunotherapy in the occurrence of secondary cancers, including lymphomas.
PMID: 31122751 [PubMed - as supplied by publisher]
Source: Annales de Dermatologie et de Cenereologie - Category: Dermatology Authors: Castel M, Cotten C, Deschamps-Huvier A, Commin MH, Marguet F, Jardin F, Duval-Modeste AB, Joly P Tags: Ann Dermatol Venereol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Dermatology | Immunotherapy | Lymphoma | Melanoma | Methotrexate | Non-Hodgkin's Lymphoma | Primary CNS Lymphoma | Rituxan | Skin | Skin Cancer | Study